|1.||Eggermann, Thomas: 2 articles (01/2010 - 01/2008)|
|2.||Schönherr, N: 2 articles (01/2008 - 09/2006)|
|3.||Xie, Qiang-min: 2 articles (01/2007 - 08/2003)|
|4.||Dincoglan, Ferrat: 1 article (01/2015)|
|5.||Sager, Omer: 1 article (01/2015)|
|6.||Beyzadeoglu, Murat: 1 article (01/2015)|
|7.||Isla, A: 1 article (10/2014)|
|8.||Kausel, G: 1 article (10/2014)|
|9.||Vera, T: 1 article (10/2014)|
|10.||Figueroa, J: 1 article (10/2014)|
|1.||Anaphylaxis (Anaphylactic Shock)
03/01/1986 - "In this study we tested the hypothesis that one factor which may distinguish between these two populations is the difference in sensitivity to a specific mediator of airway anaphylaxis, leukotriene (LT) D4 (a major component of slow reacting substance of anaphylaxis). "
02/01/1992 - "The antiallergic activities (anti-passive peritoneal anaphylaxis, anti-passive cutaneous anaphylaxis and anti-slow reacting substance of anaphylaxis activities) of the products were evaluated."
01/01/1986 - "These data indicate that O-2 generation occurring during acute airway anaphylaxis is associated with the activation of SRS-A products."
04/01/1982 - "The cardiac effects of pure synthetic LT are similar to those previously obtained with crude slow-reacting substance of anaphylaxis indicating that the prolonged contractile failure associated with systemic anaphylaxis largely could be due to the negative inotropic effect of LT. "
04/01/1979 - "In addition, several of the compounds inhibited the release of SRS-A from passively sensitized human chopped lung and protected guinea pigs from the effects of anaphylaxis in a modified Herxheimer test."
|2.||Asthma (Bronchial Asthma)
03/08/2006 - "Twenty five years after the structure elucidation of slow reacting substance of anaphylaxis, antileukotrienes are established as a new therapeutic modality in asthma. "
06/01/2001 - "One of the important chemical mediators implicated in the pathogenesis of asthma is the slow-reacting substance of anaphylaxis, which was subsequently found to comprise LTs C4, D4, and E4. "
01/14/1991 - "bronchial asthma in which the smooth muscle contractile and permeability increasing properties of SRS-A appears to contribute to the early bronchoconstrictor phase. "
05/01/1989 - "The data suggest that higher AS-B activity during asthma attacks could inactivate SRS-A and modulate allergic inflammatory reaction."
03/01/1986 - "Bronchial asthma, leukocyte synthesis of slow-reacting substance of anaphylaxis, and other evidence for activation of blood cells in asthma."
05/01/2006 - "Novel studies establish that imprinting at one of these, the IGF2-H19 domain, is epigenetically deregulated (with loss of DNA methylation) in Silver-Russell Syndrome (SRS), a congenital disease of growth retardation and asymmetry. "
10/01/2013 - "mUPD7 is the cause of approximately 5-10% of Silver-Russell syndrome (SRS), a disorder characterized by prenatal and postnatal growth retardation. "
01/01/2008 - "An opposite epimutation in the same region is associated with Silver-Russell syndrome (SRS), a growth retardation disorder characterised by a typical facial gestalt, clinodactyly V and asymmetry. "
09/01/2006 - "Recently, the opposite (epi)mutations of the same region have been reported to result in growth retardation: maternal duplications of 11p15 as well as hypomethylation of the telomeric 11p15 imprinting domain (ICR1) could be identified in patients with Silver-Russell syndrome (SRS), a disease which is in particular characterised by intrauterine and postnatal growth retardation. "
05/01/2004 - "This study examined cognitive development in Silver-Russell syndrome (SRS), a condition with intrauterine growth retardation, persisting short stature, and specific stigmata. "
|3.||Immunoglobulin E (IgE)
|7.||Histamine (Histamine Dihydrochloride)